SOURCE Sinovac Biotech Ltd.
Keep these under-$10 biotech stocks on your breakout trading radar.
Pharmaceutical companies are profiting from China’s urban ailments and a growing appetite for western-style medicinal treatments
Sinovac Biotech (Nasdaq:SVA) has been downgraded by TheStreet Ratings from from a buy to hold.
Sinovac Biotech (Nasdaq:SVA) has been upgraded by TheStreet Ratings from a hold to buy.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.